This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Georgetown University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2008.
Company Filing History:
1 out of 494 
1 out of 3,688 
Years Active: 2008
Title: John Brognard: Innovator in Pharmaceutical Compositions
Introduction
John Brognard is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of pharmaceuticals, particularly through his work on Akt inhibitors. His innovative approach has the potential to impact the treatment of various diseases and conditions.
Latest Patents
John Brognard holds a patent for "Akt inhibitors, pharmaceutical compositions, and uses thereof." This patent discloses inhibitors of the serine/threonine kinase Akt, along with pharmaceutical compositions that include these inhibitors. The method described in the patent aims to prevent or treat diseases in animals using these inhibitors. The Akt inhibitors have a specific chemical formula that includes various components, allowing for a range of applications in medical treatments.
Career Highlights
Throughout his career, John Brognard has worked with prominent organizations, including the United States Department of Health and Human Services and Georgetown University. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
John has collaborated with esteemed colleagues such as Alan P. Kozikowski and Phillip Dennis. These partnerships have contributed to the success of his research and the development of innovative pharmaceutical solutions.
Conclusion
John Brognard's contributions to the field of pharmaceuticals, particularly through his patent on Akt inhibitors, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.